NCT02517294

Brief Summary

Comparison is made between standard nasotracheal tubes and a specially designed nasotracheal tube during nasotracheal intubation in children undergoing general anesthesia for dental surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
73

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 22, 2015

Completed
10 days until next milestone

Study Start

First participant enrolled

June 1, 2015

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 7, 2015

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2019

Completed
4.5 years until next milestone

Results Posted

Study results publicly available

February 13, 2024

Completed
Last Updated

February 13, 2024

Status Verified

January 1, 2024

Enrollment Period

4.2 years

First QC Date

May 22, 2015

Results QC Date

December 6, 2023

Last Update Submit

January 23, 2024

Conditions

Keywords

Nasotracheal intubationadenoid sizeepistaxisnasopharyngeal mucosal injury

Outcome Measures

Primary Outcomes (1)

  • Number of Participants With Epistaxis

    Mucosal damage as quantified by presence and severity of bleeding immediately after passage of the NTT through the nasopharynx.

    within approximately 4hrs of surgery (day of surgery)

Secondary Outcomes (4)

  • Number of Participants With Nasotracheal Tube Impingement

    perioperative, immediate during intervention - expected 2hrs (day of surgery)

  • Number of Participants With Postoperative Epistaxis

    Participants will be followed for the duration of the hospital stay, an expected average of 6 hours

  • Number of Participants With Postoperative Croup

    end of surgery until time of discharge, approximately 4hrs

  • Time to Discharge in Minutes

    emergence from anesthesia to meeting discharge criteria, approximately 4hrs

Study Arms (2)

standard nasotracheal tube

ACTIVE COMPARATOR

Nasotracheal intubation using 'standard' side-beveled nasotracheal tubes

Device: Standard nasotracheal tube

Parker flex-tip nasotracheal tube

ACTIVE COMPARATOR

Nasotracheal intubation using 'experimental' flex-tip midline-beveled nasotracheal tubes

Device: Parker flex-tip nasotracheal tube

Interventions

specially designed nasotracheal tube used for nasotracheal intubation assess nasopharynx for severity of bleeding grade adenoid size

Parker flex-tip nasotracheal tube

standard nasotracheal tube for nasotracheal intubation assess nasopharynx for severity of bleeding grade adenoid size

standard nasotracheal tube

Eligibility Criteria

Age3 Years - 11 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • children between the ages of 3-11, ASA 1-3, presenting to Wolfson Children's Hospital (WCH) for dental procedures requiring general anesthesia with nasotracheal intubation.

You may not qualify if:

  • ASA \>3
  • known bleeding disorders
  • recent or ongoing treatment with blood-thinning medicines
  • frequent epistaxis
  • active URI/congestion/rhinorrhea
  • craniofacial abnormalities prohibiting NTI
  • known difficult airway
  • prior nasal surgery/trauma
  • allergies to any of the medicines used in this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wolfson Children's Hospital

Jacksonville, Florida, 32207, United States

Location

MeSH Terms

Conditions

Epistaxis

Condition Hierarchy (Ancestors)

Nose DiseasesRespiratory Tract DiseasesOtorhinolaryngologic DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and SymptomsSigns and Symptoms, RespiratorySigns and Symptoms

Results Point of Contact

Title
Dr Katrin Post-Martens
Organization
Nemours

Study Officials

  • Robert B Bryskin, MD

    Nemours Children's Clinic, Jacksonville, FL

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 22, 2015

First Posted

August 7, 2015

Study Start

June 1, 2015

Primary Completion

August 1, 2019

Study Completion

August 1, 2019

Last Updated

February 13, 2024

Results First Posted

February 13, 2024

Record last verified: 2024-01

Locations